Pain is a prevalent symptom in patients with lipedema predominantly impacting the lower extremities. This study aimed to evaluate the relationship between 25-hydroxyvitamin D [25(OH)D] and vitamin B12 levels and neuropathic pain (NP) in patients diagnosed with lipedema.
Methods and Results:
A total of 243 patients with lipedema who had 25(OH)D and B12 levels measured in the past 6 months were included in this study. Participants were divided into two groups: Group 1 (N = 78) with NP scores ≥13 and Group 2 (N = 165) with NP scores <13. The Turkish version of the painDETECT questionnaire was used to assess the patients’ NP symptoms. Pain levels were measured using the Visual Analog Scale (VAS) and pain threshold through algometric measurement. Group 1 had significantly higher palpation and spontaneous VAS scores, and pain threshold through algometric measurements than Group 2 (p < 0.05). No statistically significant difference was found between the groups regarding vitamin D levels being below 30 ng/mL or vitamin B12 levels being below 400 pg/mL (p > 0.05).
Conclusions:
No association was found between NP and 25(OH)D or B12 levels in patients with lipedema.
Get full access to this article
View all access options for this article.
References
1.
HerbstKL, KahnLA, IkerE, et al.Standard of care for lipedema in the United States. Phlebology, 2021; 36(10):779–796; doi: 10.1177/02683555211015887
2.
ChakrabortyA, CrescenziR, UsmanTA, et al.Indications of peripheral pain, dermal hypersensitivity, and neurogenic inflammation in patients with lipedema. Int J Mol Sci, 2022; 23(18):10313; doi: 10.3390/ijms231810313
3.
BusoG, DepaironM, TomsonD, et al.Lipedema: A call to action!. Obesity (Silver Spring), 2019; 27(10):1567–1576; doi: 10.1002/oby.22597
4.
WeisslederH, BrauerJW, SchuchhardtC, et al.Aussagewert der funktions- lymphszintigraphie und indirekten lymphangiographie beim lipödem-syndrom [Value of functional lymphoscintigraphy and indirect lymphangiography in lipedema syndrome]. Z Lymphol, 1995; 19(2):38–41.
5.
ShavitE, WollinaU, AlaviA. Lipoedema is not lymphoedema: A review of current literature. Int Wound J, 2018; 15(6):921–928; doi: 10.1111/iwj.12949
6.
PoojariA, DevK, RabieeA. Lipedema: Insights into morphology, pathophysiology, and challenges. Biomedicines, 2022; 10(12):3081; doi: 10.3390/biomedicines10123081
7.
AksoyH, KaradagAS, WollinaU. Cause and management of lipedema-associated pain. Dermatol Ther, 2021; 34(1):e14364; doi: 10.1111/dth.14364
8.
LaszkiewiczM, WillowsJW, DuboisAL, et al.Neuropathy and neural plasticity in the subcutaneous white adipose depot. PLoS One, 2019; 14(9):e0221766; doi: 10.1371/journal.pone.0221766
9.
YoungerJ, KapphahnK, BrennanK, et al.Association of leptin with body pain in women. J Womens Health (Larchmt), 2016; 25(7):752–760; doi: 10.1089/jwh.2015.5509
10.
KıranG, DebashishD. Vitamin D and rheumatoid arthritis: Is there a link? Int J of Rheum Dis, 2008; 11(3):206–211; doi: 10.1111/j.1756-185X.2008.00385.x
11.
StraubeS, Andrew MooreR, DerryS, et al.Vitamin D and chronic pain. Pain, 2009; 141(1–2):10–13; doi: 10.1016/j.pain.2008.11.010
12.
KiralySJ, KiralyMA, HaweRD, et al.Vitamin D as a neuroactive substance: Review. ScientificWorldJournal, 2006; 6:125–139; doi: 10.1100/tsw.2006.25
13.
ShiptonEA, ShiptonEE. Vitamin D and pain: Vitamin D and its role in the aetiology and maintenance of chronic pain states and associated comorbidities. Pain Res Treat, 2015; 2015:904967; doi: 10.1155/2015/904967
14.
JirikowskiGF, KaunznerUW, Dief AelE, et al.Distribution of vitamin D binding protein expressing neurons in the rat hypothalamus. Histochem Cell Biol, 2009; 131(3):365–370; doi: 10.1007/s00418-008-0540-6
15.
PlotnikoffGA, QuigleyJM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc, 2003; 78(12):1463–1470; doi: 10.4065/78.12.1463
16.
ChabasJF, StephanD, MarquesteT, et al.Cholecalciferol (vitamin D3) improves myelination and recovery after nerve injury. PLoS One, 2013; 8(5):e65034; doi: 10.1371/journal.pone.0065034
PutzZ, MartosT, NémethN, et al.Is there an association between diabetic neuropathy and low vitamin D levels? Curr Diab Rep, 2014; 14(10):537; doi: 10.1007/s11892-014-053
19.
AlamU, NelsonAJ, CuthbertsonDJ, et al.An update on vitamin D and B deficiency in the pathogenesis and treatment of diabetic neuropathy: A narrative review. Future Neurol, 2018; 13(3):135–142; doi: 10.2217/fnl-2017-0034
20.
JulianT, SyeedR, GlascowN, et al.B12 as a treatment for peripheral neuropathic pain: A systematic review. Nutrients, 2020; 12(8):2221; doi: 10.3390/nu12082221
21.
XuG, LvZW, FengY, et al.Single-center randomized controlled trial of local methylcobalamin injection for subacute herpetic neuralgia. Pain Med, 2013; 14(6):884–894; doi: 10.1111/pme.12081
22.
KuwabaraS, NakazawaR, AzumaN, et al.Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med, 1999; 38(6):472–475; doi: 10.2169/internalmedicine.38.472
23.
GharibpoorF, Ghavidel-ParsaB, SattariN, et al.Effect of vitamin B12 on the symptom severity and psychological profile of fibromyalgia patients; a prospective pre-post study. BMC Rheumatol, 2022; 6(1):51; doi: 10.1186/s41927-022-00282-y
24.
ZhangM, HanW, HuS, et al.Methylcobalamin: A potential vitamin of pain killer. Neural Plast, 2013; 2013:424651; doi: 10.1155/2013/424651
25.
AlkanH, ArdicF, ErdoganC, et al.Turkish version of the painDETECT questionnaire in the assessment of neuropathic pain: A validity and reliability study. Pain Med, 2013; 14(12):1933–1943.
26.
OzuguzU, OrucS, UluMS, et al.Does vitamin D have any role in the improvement of diabetic peripheral neuropathy in type 1 diabetic patients? J Endocrinol Invest, 2016; 39(12):1411–1417; doi: 10.1007/s40618-016-0509-6
27.
FurlanAD, LuiPW, MailisA. Chemical sympathectomy for neuropathic pain: Does it work? Case report and systematic literature review. Clin J Pain, 2001; 17(4):327–336; doi: 10.1097/00002508-200112000-00007
28.
KiloS, Harding-RoseC, HargreavesKM, et al.Peripheral CGRP release as a marker for neurogenic inflammation: A model system for the study of neuropeptide secretion in rat paw skin. Pain, 1997; 73(2):201–207; doi: 10.1016/S0304-3959(97)00108-5
29.
SchouWS, AshinaS, AminFM, et al.Calcitonin gene-related peptide and pain: A systematic review. J Headache Pain, 2017; 18(1):34; doi: 10.1186/s10194-017-0741-2
30.
MizumuraK, MuraseS. Role of nerve growth factor in pain. Handb Exp Pharmacol, 2015; 227:57–77; doi: 10.1007/978-3-662-46450-2_4
31.
LiuX, NelsonA, WangX, et al.Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts. Am J Respir Cell Mol Biol, 2014; 50(1):40–50; doi: 10.1165/rcmb.2013-0211OC
32.
CarrelliA, BucovskyM, HorstR, et al.Vitamin D storage in adipose tissue of obese and normal weight women. J Bone Miner Res, 2017; 32(2):237–242; doi: 10.1002/jbmr.2979
33.
LombardoM, FeracoA, OttavianiM, et al.The efficacy of vitamin D supplementation in the treatment of fibromyalgia syndrome and chronic musculoskeletal pain. Nutrients, 2022; 14(15):3010; doi: 10.3390/nu14153010
34.
FukuokaM, SakuraiK, OhtaT, et al.Tacalcitol, an active vitamin D 3, induces nerve growth factor production in human epidermal keratinocytes. Skin Pharmacol Appl Skin Physiol, 2001; 14(4):226–233; doi: 10.1159/000056351
35.
ShehabD, Al-JarallahK, AbdellaN, et al.Prospective evaluation of the effect of short- term oral vitamin d supplementation on peripheral neuropathy in type 2 diabetes mellitus. Med Princ Pract, 2015; 24(3):250–256; doi: 10.1159/000375304
36.
LeeP, ChenR. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med, 2008; 168(7):771–772; doi: 10.1001/archinte.168.7.771
37.
AlamU, FawwadA, ShaheenF, et al.Improvement in neuropathy specific quality of life in patients with diabetes after vitamin D supplementation. J Diabetes Res, 2017; 2017:7928083; doi: 10.1155/2017/7928083
38.
FredianiJK, LalAA, KimE, et al.The role of diet and non-pharmacologic supplements in the treatment of chronic neuropathic pain: A systematic review. Pain Pract, 2024; 24(1):186–210; doi: 10.1111/papr.13291
39.
AlkhatatbehM, Abdul-RazzakK. Neuropathic pain is not associated with serum vitamin D but is associated with female gender in patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care, 2019; 7(1):e000690; doi: 10.1136/bmjdrc-2019-000690
40.
FreynhagenR, BennettMI. Diagnosis and management of neuropathic pain. BMJ, 2009; 339:b3002; doi: 10.1136/bmj.b3002
41.
GirachA, JulianTH, VarrassiG, et al.Quality of life in painful peripheral neuropathies: A systematic review. Pain Res Manag, 2019; 2019:2091960; doi: 10.1155/2019/2091960
